Exome Asset Management’s Geron GERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-624,046
Closed -$799K – 58
2026
Q2
$799K Buy
+624,046
New +$879K 0.49% 48
2025
Q4
– Sell
-1,858,354
Closed -$2.55M – 72
2025
Q3
$2.55M Sell
1,858,354
-1,556,023
-46% -$2.07M 1.54% 28
2025
Q2
$4.81M Buy
3,414,377
+198,920
+6% +$282K 3.58% 4
2025
Q1
$5.11M Buy
3,215,457
+1,654,305
+106% +$4.03M 4.54% 3
2024
Q4
$5.62M Buy
1,561,152
+656,026
+72% +$2.62M 4.22% 3
2024
Q3
$4.11M Buy
+905,126
New +$4.12M 2.78% 9
2024
Q2
– Sell
-886,800
Closed -$2.93M – 61
2024
Q1
$2.93M Buy
886,800
+279,300
+46% +$626K 2.51% 12
2023
Q4
$1.28M Buy
+607,500
New +$1.18M 1.27% 31

Other funds holding GERN

Exome Asset Management's GERN Position: Q3 2026 in Review

Exome Asset Management sold out of Geron (GERN) in Q3 2026, closing a stake of 624,046 shares — an estimated $799K sold.

Exome Asset Management first reported a position in GERN in Q4 2023 and held it in 8 quarters. The position peaked at $5.62M in Q4 2024. 260 funds tracked by Wall St. Rank hold GERN as of Q3 2026.

  • Exome Asset Management reported no remaining Geron position as of Q3 2026 after selling out during the quarter.
  • Exome Asset Management sold 624,046 Geron shares in Q3 2026, an estimated $799K.
  • Exome Asset Management first reported a position in Geron in Q4 2023 and held it in 8 quarters.
  • Exome Asset Management's Geron position peaked at $5.62M in Q4 2024.
  • 260 funds tracked by Wall St. Rank held Geron as of Q3 2026.

Based on Exome Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.